Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
48.31
+1.28 (2.72%)
Nov 22, 2024, 4:00 PM EST - Market closed
Vera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3,059 | 683 | 535 | 569 | - | - |
| Market Cap Growth | 298.84% | 27.69% | -5.87% | - | - | - |
| Enterprise Value | 2,761 | 553 | 433 | 482 | - | - |
| Last Close Price | 48.31 | 15.38 | 19.35 | 26.72 | - | - |
| PB Ratio | 9.20 | 6.72 | 6.96 | 8.17 | - | - |
| P/TBV Ratio | 8.38 | 6.72 | 6.96 | 8.17 | - | - |
| Debt / Equity Ratio | 0.19 | 0.53 | 0.41 | 0.07 | - | 0.04 |
| Quick Ratio | 13.43 | 7.21 | 4.48 | 10.36 | 22.36 | 3.05 |
| Current Ratio | 13.76 | 7.71 | 4.91 | 10.73 | 22.55 | 3.36 |
| Return on Equity (ROE) | -65.11% | -107.50% | -121.58% | -54.43% | -198.65% | - |
| Return on Assets (ROA) | -33.37% | -41.54% | -52.81% | -31.09% | -102.70% | - |
| Return on Capital (ROIC) | -36.53% | -48.38% | -62.19% | -34.47% | -114.19% | - |
| Earnings Yield | -4.39% | -14.05% | -16.64% | -5.74% | - | - |
| FCF Yield | -3.96% | -13.50% | -12.64% | -4.17% | - | - |
| Buyback Yield / Dilution | -33.07% | -60.73% | -97.76% | -4099.14% | -8.34% | - |
| Total Shareholder Return | -33.07% | -60.73% | -97.76% | -4099.14% | -8.34% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.